| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,463,100 | 2,355,600 | 2,455,600 | 2,796,300 | | Cost of Revenue | 1,841,400 | 1,756,300 | 1,882,800 | 2,124,300 | | | Gross Profit | 621,700 | 599,300 | 572,800 | 672,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 251,600 | 272,400 | 283,200 | 272,600 | | Non Recurring | 131,700 | 48,200 | 54,200 | 1,138,200 | | Others | 145,000 | 143,700 | 148,000 | 154,100 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 93,400 | 135,000 | 87,400 | (892,900) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,600) | (1,000) | (300) | (9,400) | | Earnings Before Interest And Taxes | (98,900) | 134,000 | 87,100 | (902,300) | | Interest Expense | (119,100) | 60,000 | 59,100 | 55,400 | | Income Before Tax | 20,200 | 74,000 | 28,000 | (957,700) | | Income Tax Expense | 5,600 | 47,800 | 11,600 | (273,400) | | Minority Interest |
-
|
-
|
-
| (2,700) | | | | Net Income From Continuing Ops | 14,600 | 26,200 | 16,400 | (687,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 100 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,600 | 26,200 | 16,400 | (686,900) | | Preferred Stock And Other Adjustments | 3,500 | (1,000) | (2,500) |
-
| | | Net Income Applicable To Common Shares | $13,100 | $25,200 | $13,900 | ($686,900) |
|
0.71% Nasdaq 
Income Statement
